Apotex Recalls Paroxetine Hydrochloride Tablets Due to Chemical Contamination
Apotex Inc. is recalling Paroxetine Hydrochloride Controlled-Release Tablets because they were manufactured with active pharmaceutical ingredient batches contaminated with residual materials and solvents.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score under the rubric, as it involves a chemical contamination that could cause serious health consequences.
Plain-English summary
Apotex Inc. is recalling specific lots of Paroxetine Hydrochloride Controlled-Release Tablets, 12.5 mg, 30-count bottles. The product is a prescription medication manufactured by GlaxoSmithKline for Apotex Corp. The recall covers lots 2A001, 2A002, 2C003, 2F005, and 2G006, which have expiration dates ranging from January 2015 to July 2015.
The recall was initiated because the product was manufactured with active pharmaceutical ingredient (API) batches that were contaminated with residual materials and solvents. This chemical contamination represents a potential safety risk to patients using the medication.
The affected products were distributed nationwide and in Puerto Rico. Patients and healthcare providers should check their medication bottles for the specific lot numbers and expiration dates listed in this notice. If the medication matches the recalled lots, patients should stop using it and consult their healthcare provider or pharmacist for guidance on alternative treatment options.
The recalled product
- Product
- PAROXETINE HYDROCHLORIDE (PAROXETINE HYDROCHLORIDE)
- Brand
- PAROXETINE HYDROCHLORIDE
- Manufacturer
- Apotex Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (6)
- Lot # 2A001
- Exp. 01/15 Lot # 2A002
- Exp. 01/15 Lot # 2C003
- Exp. 03/15 Lot # 2F005
- Exp. 06/15 Lot # 2G006
- Exp. 07/15
UPCs (3)
- 0360505367436
- 0360505367535
- 0360505367337
Distribution
Part of a larger recall action
This product is one of 9 recalled by Apotex Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 9 products in this recall →Related recalls
Same brand · PAROXETINE HYDROCHLORIDE
- HighApotex Recalls Paroxetine Hydrochloride Tablets Due to Chemical Contamination
FDA (Drugs) · 2014-09-10
- SevereApotex Recalls Paroxetine Hydrochloride Tablets Due to Chemical Contamination
FDA (Drugs) · 2014-09-10
Same manufacturer · Apotex Inc.
See all →- SevereApotex Recalls Metformin Hydrochloride Extended-Release Tablets Due to NDMA Impurity
FDA (Drugs) · 2020-06-24
- SevereApotex Recalls Equate Ranitidine Tablets Due to Possible NDMA Contamination
FDA (Drugs) · 2019-11-20
- SevereApotex Recalls Walgreens Wal-Zan 150 Tablets Due to NDMA Contamination Risk
FDA (Drugs) · 2019-11-20
- SevereApotex Recalls Equate Ranitidine Tablets Due to NDMA Contamination
FDA (Drugs) · 2019-11-20
- SevereRite Aid Ranitidine Tablets Recalled for Potential NDMA Contamination
FDA (Drugs) · 2019-11-20
Same hazard · chemical contamination
See all →- SevereAmerican Regent Recalls Acetylcysteine Solution Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereGas-X Extra Strength softgels contaminated with propylene glycol machine coolant
FDA (Drugs) · 2026-06-17
- HighDragonfly Thai ginger powder may be contaminated with lead
FDA (Food) · 2026-06-17
- SevereNaproxen Oral Suspension Recalled for Lead and Lithium Contamination
FDA (Drugs) · 2026-05-13
- HighFarmHouse Fresh benzoyl peroxide night lotion recalled over benzene contamination
FDA (Drugs) · 2026-04-22